Longitudinal evaluation of manufacturer-specific differences for high-sensitive CRP EQA results

BackgroundC-reactive protein (CRP) is an established serum biomarker for different pathologies such as tissue injury and inflammatory events. One rising area of interest is the incorporation of low concentrations of CRP, so called high-sensitive (hs-) CRP, in the risk assessment and treatment monito...

Full description

Bibliographic Details

Main Authors:	Nathalie Weiss, Laura Vierbaum, Marcel Kremser, Anne Kaufmann-Stoeck, Silke Kappler, Silvia Ballert, Kathrin Kabrodt, Klaus-Peter Hunfeld, Ingo Schellenberg
Format:	Artigo
Language:	Inglês
Published:	Frontiers Media S.A. 2024-08-01
Series:	Frontiers in Molecular Biosciences
Subjects:	hsCRP external quality assessment scheme (EQA) proficiency testing (PT) harmonization cardiovascular diseases
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2024.1401405/full
Tags:	Add Tag No Tags, Be the first to tag this record!